The endocannabinoid system controls key epileptogenic circuits in the hippocampus.

By K. Monory, F. Massa, M. Egertová, M. Eder, Heike Blaudzun, R. Westenbroek, W. Kelsch, Wolfgang Jacob, Rudolph Marsch, M. Ekker and 14 more. Neuron, 2006

723 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Cognitive Neuroscience, Pharmacology

View Paper: https://www.semanticscholar.org/paper/3089c36df2576945fda79c5634f0b0914f90616e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

1. V. Di Marzo
2. Tamás F. Freund
3. I. Katona
4. R. Pertwee
5. K. Mackie
6. György Buzsáki

In Cognitive Neuroscience

1. V. Di Marzo
2. Tamás F. Freund
3. R. Pertwee

In Pharmacology

1. V. Di Marzo
2. Tamás F. Freund
3. I. Katona
4. R. Pertwee
5. K. Mackie
6. U. Kumar
7. Shenglong Zou

Citations in the corpus

• Endocannabinoid signaling as a synaptic circuit breaker in neurological disease (2008, background): “The underlying cellular and molecular processes of the involvement of synaptic endocannabinoid signaling in the brain's own protective system began to unfold after development of mouse models in which CB 1 receptors were deleted exclusively from selected cell type”
• Dendritic excitability and synaptic plasticity. (2008, neutral): “nabinoid signaling in fact promotes epilepsy (498, 533),”
• Targeting the endocannabinoid system: to enhance or reduce? (2008, background): “2 ), endocannabinoids might be upregulated first to target only glutamatergic CB 1 -expressing cell”
• The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin (2008, background): “Moreover, CB1 receptors in mouse hippocampus are more highly expressed by GABAergic interneurons than glutamatergic principal neurons (Monory et al., 2006).”